Morepen Labs: Sanjay Suri elevated to Managing Director

Morepen Laboratories Ltd. announced the elevation of Mr. Sanjay Suri from Whole-time Director to Managing Director, effective July 1, 2026. This decision was made by the Board of Directors on June 30, 2026, based on the Nomination and Remuneration Committee's recommendation. His new role is for the balance of his existing term, until August 12, 2028, subject to shareholder approval. As Managing Director, Mr. Sanjay Suri will jointly oversee the company's management and operations alongside Mr. Sushil Suri, the Chairman & Managing Director. Mr. Sanjay Suri, a Bachelor of Science, brings over thirty years of experience in the pharmaceuticals industry, covering international sales, marketing, joint ventures, regulatory approvals (including USFDA), strategic planning, manufacturing, finance, accounts, and banking. He is also a member of the promoter group and brother of Mr. Sushil Suri.